243 related articles for article (PubMed ID: 21893546)
1. Cancer vaccines.
Liu MA
Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2823-6. PubMed ID: 21893546
[TBL] [Abstract][Full Text] [Related]
2. Cancer vaccines: emphasis on pediatric cancers.
Guinipero T; Finn OJ
Curr Pharm Des; 2010 Jan; 16(3):292-9. PubMed ID: 20109138
[TBL] [Abstract][Full Text] [Related]
3. [Oncoimmunology: some fundamental problems of cancer immunotherapy].
Nedospasov SA; Kuprash DV
Mol Biol (Mosk); 2007; 41(2):355-68. PubMed ID: 17514902
[TBL] [Abstract][Full Text] [Related]
4. Cancer vaccines: between the idea and the reality.
Finn OJ
Nat Rev Immunol; 2003 Aug; 3(8):630-41. PubMed ID: 12974478
[TBL] [Abstract][Full Text] [Related]
5. [Immunology of cancer].
Abelev GI
Vestn Ross Akad Med Nauk; 1999; (4):21-5. PubMed ID: 10377879
[TBL] [Abstract][Full Text] [Related]
6. Recent developments in therapeutic cancer vaccines.
Morse MA; Chui S; Hobeika A; Lyerly HK; Clay T
Nat Clin Pract Oncol; 2005 Feb; 2(2):108-13. PubMed ID: 16264883
[TBL] [Abstract][Full Text] [Related]
7. Biological therapy: approaches in colorectal cancer. Strategies to enhance carcinoembryonic antigen (CEA) as an immunogenic target.
Zbar AP; Lemoine NR; Wadhwa M; Thomas H; Snary D; Kmiot WA
Br J Cancer; 1998 Mar; 77(5):683-93. PubMed ID: 9514045
[No Abstract] [Full Text] [Related]
8. Therapeutic cancer vaccines.
Saxena M; van der Burg SH; Melief CJM; Bhardwaj N
Nat Rev Cancer; 2021 Jun; 21(6):360-378. PubMed ID: 33907315
[TBL] [Abstract][Full Text] [Related]
9. Translating tumor antigens into cancer vaccines.
Buonaguro L; Petrizzo A; Tornesello ML; Buonaguro FM
Clin Vaccine Immunol; 2011 Jan; 18(1):23-34. PubMed ID: 21048000
[TBL] [Abstract][Full Text] [Related]
10. Tumor immunology top 10 list.
Finn OJ
Immunol Rev; 2008 Apr; 222():5-8. PubMed ID: 18363991
[No Abstract] [Full Text] [Related]
11. 'Final common pathway' of human cancer immunotherapy: targeting random somatic mutations.
Tran E; Robbins PF; Rosenberg SA
Nat Immunol; 2017 Feb; 18(3):255-262. PubMed ID: 28198830
[TBL] [Abstract][Full Text] [Related]
12. Human tumor antigens, immunosurveillance, and cancer vaccines.
Finn OJ
Immunol Res; 2006; 36(1-3):73-82. PubMed ID: 17337768
[TBL] [Abstract][Full Text] [Related]
13. Progress on new vaccine strategies for the immunotherapy and prevention of cancer.
Berzofsky JA; Terabe M; Oh S; Belyakov IM; Ahlers JD; Janik JE; Morris JC
J Clin Invest; 2004 Jun; 113(11):1515-25. PubMed ID: 15173875
[TBL] [Abstract][Full Text] [Related]
14. The present status and future prospects of peptide-based cancer vaccines.
Hirayama M; Nishimura Y
Int Immunol; 2016 Jul; 28(7):319-28. PubMed ID: 27235694
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy for cancer--modern immunologic strategies in oncology].
Halama N; Zoernig I; Jäger D
Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
[TBL] [Abstract][Full Text] [Related]
16. Cancer vaccines: what do we need to measure in clinical trials?
Kudrin A
Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
[TBL] [Abstract][Full Text] [Related]
17. Clinical promise of tumour immunology.
Scott AM; Cebon J
Lancet; 1997 May; 349 Suppl 2():SII19-22. PubMed ID: 9164443
[No Abstract] [Full Text] [Related]
18. Immune surveillance as a rationale for immunotherapy?
Pashov A; Monzavi-Karbassi B; Chow M; Cannon M; Kieber-Emmons T
Hum Vaccin; 2007; 3(5):224-8. PubMed ID: 17660717
[TBL] [Abstract][Full Text] [Related]
19. Vaccines and other immunological approaches for cancer immunoprevention.
Lollini PL; Nicoletti G; Landuzzi L; Cavallo F; Forni G; De Giovanni C; Nanni P
Curr Drug Targets; 2011 Dec; 12(13):1957-73. PubMed ID: 21158706
[TBL] [Abstract][Full Text] [Related]
20. The role of antigen-specific and non-specific immunotherapy in the treatment of cancer.
Monjazeb AM; Hsiao HH; Sckisel GD; Murphy WJ
J Immunotoxicol; 2012; 9(3):248-58. PubMed ID: 22734880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]